Abstract

In conditions of the knowledge economy and innovations, research and development activities are among the most important factors affecting companies’ financial performance. This study aims to investigate the impact of research and development activities on the profitability of Slovak pharmaceutical companies. The panel dataset consists of 37 sample pharmaceutical companies for 2015-2019. Panel data regression analysis was used as the main research method of the study. Profitability was measured with the return on assets indicator, chosen as the dependent variable. The independent variables are leverage, research and development intensity, research and development intensity squared, size, and high-tech dummy. The empirical analysis includes descriptive statistics, normality test, autocorrelation test, and panel regression models (random effect model) followed by F-statistics test, Hausman test, and Breusch-Pagan test. The hypothesis that there is a significant positive impact of research and development activities on the profitability of knowledge-intensive enterprises has been partly confirmed. Only the research and development intensity squared has a significant positive impact on the profitability of Slovak pharmaceutical companies at a 1% level. On the contrary, the research and development intensity has a significant negative relation. According to the analysis results, control variables (leverage, size, and high-tech dummy) have no significant influence on profitability. The existence of an inverted-U relationship between research and development activities and the profitability of Slovak pharmaceutical companies has been established. Investing in innovations of Slovak pharmaceutical companies has a positive effect on profitability only from a certain amount and has an upper limit on the amount of profitable investment. Thus, to formulate recommendations on the adjustment of investment policy in research and development activities, it is necessary to conduct future research to determine the entry points and exit points from the area of best profitability on inverted-U function.

Keywords: financial performance, pharmaceutical companies, profitability, research and development

JEL Classification: E31, L16, O14.

Cite as: Lehenchuk, S., Tumpach, M., Vyhivska, I., Makarovych, V., & Laichuk, S. (2022). The Impact of Innovation on the Profitability of Slovak Pharmaceutical Companies. Marketing and Management of Innovations, 2, 284-296. https://doi.org/10.21272/mmi.2022.2-25

This work is licensed under a Creative Commons Attribution 4.0 International License

References

1. Archarungroj, P., & Hoshino, Y. (1999). Firm size and R&D on profitability: An empirical analysis on Japanese chemical and pharmaceutical industry. Japanese Journal of Administrative Science, 13(2), 71-86. [Google Scholar] [CrossRef]
2. Ayaydin, H., & Karaaslan, I. (2014). The effect of research and development investment on firms’ financial performance: evidence from manufacturing firms in Turkey. The Journal of Knowledge Economy & Knowledge Management, 9, 43-59. [Google Scholar]
3. Brimah, B. A., Bamidele, A. G., Rabiu, R. O., & John, I. S. (2020). The Connexus of Management by Objectives and Organisational Performance: Evidence from Tuyil Pharmaceutical Limited, Ilorin. SocioEconomic Challenges, 4(2), 90-98. [Google Scholar] [CrossRef]
4. Dalvadi, Y. M., & Mansuri, S. I. (2018). A Study on Impact of Profitability and R&D Intensity on R&D Expenditure in Selected Pharmaceutical Companies. Al-Barkaat Journal of Finance & Management, 10(1), 25-33. [Google Scholar] [CrossRef]
5. Del Monte, A., & Papagni, E. (2003). R&D and the growth of firms: empirical analysis of a panel of Italian firms. Research policy, 32(6), 1003-1014. [Google Scholar] [CrossRef]
6. Eldawayaty, D. M. A. (2020). The Impact of Research and Development (R&D) Intensity on Financial Performance and Firm Value: An Empirical Study on Pharmaceutical Companies Listed on Egyptian Stock Exchange. Alexandria Journal of Accounting Research, 4(3), 1-55. [Link]
7. Erdogan, M., & Yamaltdinova, A. (2019). A panel study of the impact of R&D on financial performance: Evidence from an emerging market. Procedia Computer Science, 158, 541-545. [Google Scholar] [CrossRef]
8. Fortune, A., & Shelton, L. (2012). R&D effort, effectiveness, and firm performance in the pharmaceutical sector. Journal of business and management, 18(1), 97-115. [Google Scholar]
9. Freihat, A. R. F., & Kanakriyah, R. (2017). Impact of R&D expenditure on financial performance: Jordanian evidence. European Journal of Business and Management, 9(32), 73-83. [Google Scholar]
10. Holobiuc, A.-M. (2021). Determinants of economic growth in the European Union. An empirical analysis of conditional convergence. SocioEconomic Challenges, 5(2), 26-34. [Google Scholar] [CrossRef]
11. Griliches, Z. (1979). Issues in Assessing the Contribution of Research and Development to Productivity Growth. The Bell Journal of Economics, 10(1), 92-116. [CrossRef]
12. Ievdokymov, V., Ostapchuk, T., Lehenchuk, S., Grytsyshen, D., & Marchuk, G. (2020). Analysis of the impact of intangible assets on the companies’ market value. Naukovyi Visnyk Natsionalnoho Hirnychoho Universytetu, 3, 164-170. [Google Scholar] [CrossRef]
13. Jen Huang, C., & Ju Liu, C. (2005). Exploration for the relationship between innovation, IT and performance. Journal of Intellectual Capital, 6(2), 237-252. [CrossRef]
14. Kliestik, T., Nica, E., Suler, P., & Valaskova, K. (2020). Innovations in the Company’s Earning Management: The Case for the Czech Republic and Slovakia. Marketing and Management of Innovations, 3, 332-345. [CrossRef]
15. Lahmini, H. M., Mialed, K., & Mokhlis, C. E. (2020). Management of Companies Performance: Impact of Immaterial Capital. Marketing and Management of Innovations, 3, 45-58. [CrossRef]
16. Lipkova, L., & Braga D. (2016). Measuring commercialization success of innovations in the EU. Marketing and Management of Innovations, 4, 15-30. [Link]
17. Lome, O., Heggeseth, A.G., & Moen, Ø. (2016). The effect of R&D on performance: Do R&D-intensive firms handle a financial crisis better? The Journal of High Technology Management Research, 27(1), 65-77. [Google Scholar] [CrossRef]
18. Monahan, S. (2005). Conservatism, Growth and the Role of Accounting Numbers in the Fundamental Analysis Process. Review of Accounting Studies, 10, 227-260. [Google Scholar] [CrossRef]
19. Nandy, M. (2020). Is There Any Impact of R&D on Financial Performance? Evidence from Indian Pharmaceutical Companies. FIIB Business Review, 9(4), 319-334. [Google Scholar] [CrossRef]
20. Natasha, I. E., & Yanthi, R. I. H. (2009). The analysis of R&D impact on the public listed companies’ performance in Indonesia. Journal of Applied Finance and Accounting, 1(2), 339-350. [Google Scholar] [CrossRef]
21. Nord, L.J. (2011). R&D Investment Link to Profitability: A Pharmaceutical Industry Evaluation. Undergraduate Economic Review, 8(1), 1-6. [Google Scholar] [Link]
22. Ozkan, N. (2022). R&D spending and financial performance: an investigation in an emerging market. International Journal of Management Economics and Business, 18(1), 38-58. [Google Scholar] [CrossRef]
23. Pharmaceutical & Life Sciences Sector in Slovakia (2022). Slovak Investment and Trade Development Agency. English edition. 19 p. [Link]
24. Qi, E., & Deng, M. (2019). R&D Investment Enhance the Financial Performance of Company Driven by Big Data Computing and Analysis. Computer systems science and engineering, 34(4), 237-248. [Link]
25. Rafiq, Sh., Salim, R., & Smyth, R. (2016). The moderating role of firm age in the relationship between R&D expenditure and financial performance: Evidence from Chinese and US mining firms. Economic Modelling, 56, 122-132. [Google Scholar] [CrossRef]
26. Serpeninova, Yu., Makarenko, I., Plastun, A., Babko, A., & Gasimova, G. (2020). Mapping of the responsible investments instruments in sdg 3 ‘good health and well-being’ financing: EU and US experience. Health Economics and Management Review, 1(1), 106-115. [Google Scholar] [CrossRef]
27. Shasha, L. (2021). The Influence of Technological Innovation on the Profitability of Enterprises. 2020 International Conference on New Energy Technology and Industrial Development (NETID 2020). E3S Web of Conferences, 235. [Google Scholar] [CrossRef]
28. Varahrami, V. (2015). Effects of R&D Costs on Profit of Producers of Oil Productions in Tehran Stock Exchange. Journal of Social and Administrative Sciences, 2(3), 132-134. [Google Scholar] [CrossRef]